363 results on '"Nadler, L. M."'
Search Results
2. Alloanergization of Human T Cells Results in Expansion of Alloantigen-Specific CD8+CD28− Suppressor Cells
3. Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling
4. Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients
5. A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2
6. Transplantation with anti-B1 monoclonal antibody and complement treated autologous bone marrow for relapsed B-cell non-Hodgkin’s lymphoma
7. Human B Cell-Associated Antigens: Expression on Normal and Malignant B Lymphocytes
8. Follicular lymphoma cells stimulated through CD40 can prime alloantigen-specific T cell responses against primary malignant cells
9. Antigen-presenting function of B-cell precursor malignant cells can be modulated by crosslinking of CD40
10. The T lymphoblastic malignancies
11. Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell
12. Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling
13. mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells
14. Long term outcome of patients with mantle cell lymphoma following autologous stem cell transplantation
15. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
16. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
17. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
18. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.
19. Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation.
20. A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB.
21. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct.
22. Differential expression of alternate mB7-2 transcripts.
23. Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.
24. Characterization of the murine B7-1 genomic locus reveals an additional exon encoding an alternative cytoplasmic domain and a chromosomal location of chromosome 16, band B5.
25. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy.
26. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.
27. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells.
28. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
29. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance.
30. Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation?
31. Characterization of CTLA-4 structure and expression on human T cells.
32. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.
33. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.
34. Bone Marrow Purging for Autologous Bone Marrow Transplantation
35. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression
36. Early signaling defects in human T cells anergized by T cell presentation of autoantigen.
37. Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.
38. Growth arrest of human B lymphocytes is accompanied by induction of the low molecular weight mammalian heat shock protein (Hsp28).
39. Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex.
40. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.
41. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.
42. Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma.
43. Alloanergization of Human T Cells Results in Expansion of Alloantigen‐Specific CD8+CD28−Suppressor Cells
44. THE BIOLOGY OF SAA: IDENTIFICATION OF THE INDUCER, IN VITRO SYNTHESIS, AND HETEROGENEITY DEMONSTRATED WITH MONOCLONAL ANTIBODIES*.
45. Clinical, pathologic and immunologic features of patients with non-Hodgkin's lymphoma in a leukemic phase. A retrospective analysis of 34 patients.
46. T-cell lymphoblastic lymphoma with subsequent acute nonlymphocytic leukemia: a case report.
47. Lymphoid subpopulations of peripheral blood and spleen in untreated Hodgkin's disease.
48. mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells.
49. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
50. Tumor-specific adoptive T-cell therapy for CD40+ B-cell malignancies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.